Marriott Vacations (VAC) Q4 2025 earnings review
Massive Impairment and Volume Declines Overshadow Stable EBITDA
Marriott Vacations reported a massive $546 million non-cash impairment in Q4, driving a $431 million net loss. The write-downs target legacy ILG goodwill, Welk inventory, and halted North American projects, signaling a harsh structural cleanup. While Adjusted EBITDA of $186 million came in near the high end of guidance, the underlying volume metrics are decelerating: Contract Sales fell 4% year-over-year, driven by a 3% drop in tours and lower Volume Per Guest (VPG). FY26 guidance projects sluggish 1-2% growth in sales and EBITDA, suggesting that the highly touted 'Modernization Program' is merely offsetting core business erosion rather than driving true top-line expansion.
๐ Bull Case
Despite top-line struggles, FY26 Adjusted Free Cash Flow is guided to surge to $375-$425 million (up from $145 million in FY25), providing ample ammunition for deleveraging and stock buybacks.
The $546 million impairment clears out dead weight from the ILG and Welk acquisitions, allowing the newly appointed President & COO Mike Flaskey to focus purely on cash-generating assets and operational efficiency.
๐ป Bear Case
Tours have reversed from growth to a 3% decline in Q4, and VPG continues to drop. If the company cannot get prospective buyers through the door, long-term owner base expansion is at risk.
Management previously promised $150-$200 million in run-rate EBITDA benefits from its Modernization Program by 2026. However, FY26 EBITDA guidance implies only ~$16 million in actual YoY growth, meaning base operations are heavily degrading.
โ๏ธ Verdict: ๐ด
Bearish. The 'clean up the balance sheet' narrative is a positive step, but you cannot shrink your way to sustainable growth. The reversal in tour flow and continued VPG weakness point to a stalling core business.
Key Themes
Massive Asset Write-Downs and Strategy Pivot
The company took a sudden $546 million non-cash impairment in Q4. This included $184 million to write down ILG acquisition goodwill, $160 million for real estate identified for disposition, and $175 million related to halted future phases of North American projects and Legacy-Welk inventory. This signals a sharp reversal from aggressive expansion to capital-efficient contraction.
Tour Volumes Reversing into Contraction
After management leaned heavily on 'First-Time Buyer' growth earlier in the year to offset Volume Per Guest (VPG) weakness, the funnel is now drying up. Total tours fell 3% YoY in Q4 (109,965 vs 113,828), a worsening deceleration from Q3's 1% decline. Without tour growth, the company will struggle to seed its future pipeline of recurring maintenance and upgrade revenues.
Exchange & Third-Party Management Bleeding Continues
The segment remains a steady drag on results. Segment Adjusted EBITDA declined 13% YoY in Q4 to $19 million. Total active Interval International members fell 2% to 1.507 million, marking a continuous multi-quarter slide as the legacy exchange model loses relevance.
Aggressive Disposition and Capital Return
Management executed a strategic sale of the Westin Resort & Spa in Cancun for $50 million in January 2026. This ties directly into their new focus on liquidity generation, allowing them to repay $575 million of maturing convertible debt and supporting the massive ramp in expected FY26 Free Cash Flow.
Other KPIs
Decelerating significantly compared to $285 million in FY24, primarily due to modernization costs, restructuring, and lower operating profit. However, the company expects a massive rebound in 2026.
Stable. The sales reserve stood at 12.7% of contract sales, net of resales. Management noted that delinquencies declined on a YoY basis for the fourth consecutive quarter, offering a rare bright spot for consumer credit health.
GAAP segment margin completely collapsed due to the $364 million impairment charge assigned specifically to this segment. On an Adjusted EBITDA basis, margins slightly expanded by 70 bps YoY to 27.9%, showcasing decent cost controls underlying the massive write-downs.
Guidance
Stable but uninspiring. The midpoint of $1,780 million implies barely a 1% growth over FY25's $1,762 million. This indicates management expects top-line pressure to persist through the entirety of the next year.
Decelerating growth vs long-term targets. The midpoint ($767.5M) implies just 2% growth over FY25 ($751M). Note: Q1 2026 will introduce an accounting change moving warehouse credit facility interest into operating expenses, dragging this metric down by an estimated $10-$15 million.
Accelerating dramatically. The midpoint of $400 million represents a 175% increase over FY25. This massive jump is the true bull case for the stock and is likely driven by lower planned capital expenditures, inventory rationalization, and the conclusion of cash-heavy modernization spend.
Key Questions
Modernization Program Net Impact
In previous quarters, you guided to $150-$200 million in run-rate EBITDA benefits from the Modernization Program by the end of 2026. Given FY26 EBITDA guidance implies only roughly $16 million in total YoY growth, how much of your base business is eroding to offset these savings?
Halted North American Projects
You took a $175 million impairment partly related to future phases of North American projects you no longer expect to build. Can you specify which markets are being abandoned and whether this is due to construction costs, softening demand, or capital reallocation?
Tour Volume Strategy
Tours turned negative, falling 3% in Q4 after declining 1% in Q3. With the new COO Mike Flaskey coming on board, what specific operational changes will be implemented to reverse this traffic decline without sacrificing FICO quality?
